MagicMed Industries has inked an amalgamation agreement with medical CBD biotech Enveric Biosciences (NASDAQ: ENVB). Psilocybin Alpha understands MagicMed will be acquired by the listed company via an all-stock transaction. Upon closing of the transaction, MagicMed’s CEO Dr. Joseph Tucker would be appointed CEO of Enveric Biosciences; Enveric’s current CEO, David Johnson…
